AmoyDx Medical: No IVDD Stablecoin or Exchange Launched
- No official announcements or evidence support the stablecoin rumor.
- Corporate leadership has not discussed crypto initiatives.
- No financial or market activity related to this initiative.
AmoyDx Medical, a Hong Kong-listed company, has no official announcement regarding launching an IVDD stablecoin or “IVDNewCo Exchange” as of July 18, 2025.
The event highlights the ongoing surge in unverified cryptocurrency news, raising questions about speculative reporting in the digital asset industry.
Background on Rumors
AmoyDx Medical, known for its focus on diagnostics in oncology, has been subject to speculation regarding a supposed launch of an IVDD stablecoin. As of July 18, 2025, no official evidence supports these claims on their platforms.
The rumors circulate despite no statements from AmoyDx’s executive team or corporate leaders about any involvement in cryptocurrency or exchange products. Official sources highlight their commitments to molecular diagnostics exclusively. The speculation has not affected any existing cryptocurrencies or created shifts in the digital asset market, contrary to some reports. AmoyDx continues operations in diagnostics without venturing into digital currencies.
Importance of Verified Information
Issues in speculative reporting emphasize the need for verified information in crypto markets. AmoyDx remains focused on its diagnostics mission without any crypto engagements.
Industry experts suggest these rumors exhibit the growing challenges in maintaining accurate information flow, particularly with the unregulated nature of cryptocurrency discussions. This reflects the consensus from a review of primary sources, including the official website and press releases, as such, no direct quotes can be extracted that affirm these developments. This instance stresses the value of trusted sources and verified announcements before spreading news in financially sensitive markets.
